Achieve Life Sciences (ACHV) Receivables - Net (2010 - 2023)
Achieve Life Sciences' (ACHV) quarterly Receivables - Net came in at $111000.0 in Q4 2023, up 5.71% YoY from $105000.0 in Q4 2022, and up 33.73% on a QoQ basis from $83000.0 in Q3 2023.
Achieve Life Sciences (ACHV) Receivables - Net (2010 - 2023) Analysis & Trends
Achieve Life Sciences (ACHV) has 13 years of Receivables - Net data on file, last reported at $111000.0 in Q4 2023.
- Quarterly Receivables - Net rose 5.71% year-over-year to $111000.0 in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $111000.0 (up 5.71% YoY) and the FY2023 annual result came in at $111000.0, up 5.71% from the prior year.
- Receivables - Net rose to $111000.0 in Q4 2023, from $83000.0 in the prior quarter.
- In the past five years, Receivables - Net ranged from a high of $350000.0 in Q2 2023 to a low of $8000.0 in Q4 2019.
- A 4-year average of $150800.0 and a median of $128000.0 in 2022 frame the typical range for Receivables - Net.
- Annual changes were most pronounced in 2019 — Receivables - Net increased 14.29% — and 2023, when it tumbled 42.76%.
- Tracing ACHV's Receivables - Net over 4 years: stood at $8000.0 in 2019, then soared by 1812.5% to $153000.0 in 2021, then slumped by 31.37% to $105000.0 in 2022, then increased by 5.71% to $111000.0 in 2023.
- The last three Receivables - Net figures came in at $111000.0 (Q4 2023), $83000.0 (Q3 2023), and $350000.0 (Q2 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Achieve Life Sciences | 330.88 Mn | 330.88 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 111,000.00 |
| Dec 31, 2023 | 111,000.00 |
| Sep 30, 2023 | 83,000.00 |
| Sep 30, 2023 | 83,000.00 |
| Jun 30, 2023 | 350,000.00 |
| Jun 30, 2023 | 350,000.00 |
| Mar 31, 2023 | 89,000.00 |
| Mar 31, 2023 | 89,000.00 |
| Dec 31, 2022 | 105,000.00 |
| Dec 31, 2022 | 105,000.00 |
| Sep 30, 2022 | 145,000.00 |
| Sep 30, 2022 | 145,000.00 |
| Jun 30, 2022 | 313,000.00 |
| Jun 30, 2022 | 313,000.00 |
| Dec 31, 2021 | 153,000.00 |
| Dec 31, 2021 | 153,000.00 |
| Sep 30, 2021 | 151,000.00 |
| Sep 30, 2021 | 151,000.00 |
| Dec 31, 2019 | 8,000.00 |
| Dec 31, 2019 | 8,000.00 |